Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 966 of 6351
-
Glow-in-the-Dark drug could slash repeat breast cancer surgeries
Disease control Stopped earlyBreast conserving surgery (BCS) is performed on patients with breast cancer to resect and completely remove the cancer while conserving as much of the surrounding healthy tissue as possible. Current methods do not allow surgeons to determine the completeness of surgical resection…
Phase 3 • Sponsor: SBI ALApharma Canada, Inc. • Aim: Disease control
Last updated Jun 26, 2026 12:47 UTC
-
Old diabetes drug, new hope: could metformin stop myeloma before it starts?
Prevention OngoingThe purpose of this research is to understand whether the drug metformin could be used in the future to help prevent patients with monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) from developing multiple myeloma. The names of the s…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Prevention
Last updated Jun 27, 2026 09:03 UTC
-
Liver cancer hope: new combo tested after standard treatment fails
Disease control OngoingThis is a Phase III, open-label, multicenter, randomized, two-arm study designed to evaluate the efficacy and safety of atezolizumab plus either lenvatinib or sorafenib versus lenvatinib or sorafenib alone in participants with locally advanced or metastatic Hepatocellular Carcino…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New drug shows promise for Long-Term control of rare Muscle-Weakening disease
Disease control CompletedThe purpose of this study is to evaluate the long-term safety and tolerability of efgartigimod PH20 SC 1000 mg, and the clinical efficacy, PD, pharmacokinetics (PK), immunogenicity, impact on the quality of life (QoL) of the participants, treatment satisfaction, and administratio…
Phase 3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could a cancer drug tame kaposi sarcoma in HIV patients?
Disease control CompletedThis phase II clinical trial studies the side effects of pomalidomide and how well it works in treating patients with Kaposi sarcoma and human immunodeficiency virus (HIV) infection. Biological therapies, such as pomalidomide, may stimulate the immune system in different ways and…
Phase 2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New blood test algorithm could speed up heart failure diagnosis in ER
Diagnosis OngoingAcute heart failure is a life-threatening condition where the heart is suddenly unable to pump blood around the body. It can be challenging to diagnose because the symptoms often mimic other conditions. Previous studies have showed that delays in making the correct diagnosis resu…
Sponsor: University of Edinburgh • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
New COVID-19 vaccine trial includes children as young as 3
Vaccine Completedphase I study will evaluate safety and immunogenicity of a recombinant SARS-CoV-2 vaccine (CHO cell) in Chinese healthy population aged 3 years and older. 300 subjects will be enrolled and divided into 5 age groups: 18-59 years old group, 60-69 years old group, ≥70 years old grou…
Phase 1/2 • Sponsor: National Vaccine and Serum Institute, China • Aim: Vaccine
Last updated Jun 27, 2026 08:11 UTC
-
New procedure aims to stop repeat hip fractures in osteoporosis patients
Prevention Recruiting nowA randomized controlled trial to evaluate AGN1 to prevent secondary hip fractures in osteoporotic women undergoing treatment of index hip fractures. Up to 2400 subjects will be randomized between a treatment group and a control group. Subjects will be followed for a minimum of 5 …
Sponsor: AgNovos Healthcare, LLC • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
Ambulance injection could change heart attack care
Disease control OngoingThis is a Phase 3 prospective, blinded, randomized, placebo controlled, international multicenter study. Subjects with STEMI will be enrolled in the ambulance if they meet all eligibility criteria. These subjects will be evaluated by (para)medics who transport the subjects to the…
Phase 3 • Sponsor: CeleCor Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New Gene-Based bladder cancer treatment shows promise in early trial
Disease control Recruiting nowThis study will evaluate the safety and efficacy of intravesical administration of detalimogene (EG-70) in the bladder and its effect on bladder tumors in patients with NMIBC. This study study consists of two phases; a Phase 1 dose-escalation to establish safety and recommended …
Phase 1/2 • Sponsor: enGene, Inc. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a 'Microbiome Transplant' stop recurring vaginal infections?
Disease control Recruiting nowThis is a randomized trial of vaginal microbiome transplant vs. saline placebo to restore a Lactobacillus dominant vaginal microbial community in women with recurrent bacterial vaginosis.
Phase 1/2 • Sponsor: Douglas Kwon • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New biologic shot could ease severe nasal polyps
Disease control CompletedA Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study of Tezepelumab in Participants with Severe Chronic Rhinosinusitis with Nasal Polyposis
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Immune cells take on tough tumors in early trial
Disease control Recruiting nowThis is a single-center, single-arm phase I clinical trial.The study process was divided into: screening period, sampling and production period, NMA-LD chemotherapy , treatment and observation period, and follow-up period.
Phase 1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New combo therapy aims to boost immune response in hard-to-treat breast cancers
Disease control Recruiting nowThe purpose of this study is to find out whether adding pembrolizumab, with or without olaparib, to standard radiation therapy is a safe and effective treatment for metastatic breast cancer, , and to see whether the study treatment is better than, the same as, or worse than the u…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can two drugs together tackle tough lung cancer?
Disease control Stopped earlyThis is an open-label, multicenter Phase Ib/II registration clinical study, consisting of two parts: the Phase Ib dose-climbing study and the Phase II efficacy exploration study. Phase Ib : Phase Ib is a multicenter, single-arm study evaluating the safety, tolerability, and pre…
Phase 1/2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New hope for COVID-19 patients on ventilators: drug combo trial completed
Disease control CompletedThis study looks at the safety and effectiveness of different drugs in treating COVID-19 in people who have been hospitalized with the infection and who have acute respiratory failure. Participants in the study will be treated with either a study drug plus current standard of car…
Phase 3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Could a common antibiotic boost chemo for tough breast cancer?
Disease control Recruiting nowThe primary objective of this study is to compare progression-free survival (PFS) of patients with metastatic triple-negative breast cancer randomised to treatment with standard chemotherapy plus moxifloxacin or placebo.
Phase 3 • Sponsor: Sun Yat-Sen University Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Cancer drug shows promise for lupus kidney disease
Disease control OngoingThe purpose of this research is to study the safety and efficacy of daratumumab in inducing complete or partial remission in patients with active lupus nephritis.
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New program aims to keep teens off opioids with medication and support
Disease control Recruiting nowThe Houston Emergency Response Opioid Engagement System for Youths and Adolescents (Young HEROES) is a community-based research program integrating assertive outreach, medication for opioid use disorder (MOUD), behavioral counseling, and peer recovery support. The objective is to…
Phase 4 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New combo attack: surgery and drugs take on tough liver cancer
Disease control OngoingThe treatment strategies for HCC with PVTT is still controversial, and differ substantially between the west and the east. According to western guidelines, including those of the EASL, BCLC, and AASLD, PVTT is regarded as a contra-indication to initial surgery or transarterial ch…
Phase 3 • Sponsor: Jia Fan • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC